[
  {
    "date": "2023-12-30",
    "symbol": "FGEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "FGEN",
    "entityregistrantname": "FIBROGEN, INC.",
    "entitycentralindexkey": 921299,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-36740",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "77-0357827",
    "entityaddressaddressline1": "409 Illinois Street",
    "entityaddresscityortown": "San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94158,
    "cityareacode": 415,
    "localphonenumber": "978-1200",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "San Jose, California",
    "cashandcashequivalentsatcarryingvalue": 113688000,
    "shortterminvestments": 121898000,
    "accountsreceivablenetcurrent": 12553000,
    "inventorynet": 41565000,
    "prepaidexpenseandotherassetscurrent": 41855000,
    "assetscurrent": 331559000,
    "restrictedcashandcashequivalentsnoncurrent": 1658000,
    "propertyplantandequipmentnet": 13126000,
    "equitymethodinvestments": 5290000,
    "operatingleaserightofuseasset": 68093000,
    "otherassetsnoncurrent": 3803000,
    "assets": 423529000,
    "accountspayablecurrent": 17960000,
    "accruedliabilitiesandotherliabilities": 172891000,
    "contractwithcustomerliabilitycurrent": 12740000,
    "operatingleaseliabilitycurrent": 14077000,
    "liabilitiescurrent": 217668000,
    "accruedproductdevelopmentcosts": 17763000,
    "contractwithcustomerliabilitynoncurrent": 157555000,
    "operatingleaseliabilitynoncurrent": 66537000,
    "securedlongtermdebt": 71934000,
    "liabilityrelatedtosaleoffuturerevenuesnoncurrent": 51413000,
    "otherliabilitiesnoncurrent": 2858000,
    "liabilities": 585728000,
    "redeemablenoncontrollinginterestequitycarryingamount": 21480000,
    "commonstockvalue": 988000,
    "additionalpaidincapital": 1643641000,
    "accumulatedothercomprehensiveincomelossnetoftax": -6875000,
    "retainedearningsaccumulateddeficit": -1841920000,
    "stockholdersequity": -204166000,
    "nonredeemablenoncontrollinginterest": 20487000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -183679000,
    "liabilitiesandstockholdersequity": 423529000,
    "accountsreceivablenetcurrentrelatedparties": 6079000,
    "otherliabilitiescurrentduetorelatedparties": 39814000,
    "duetorelatedpartiesdeferredrevenuecurrent": 7220000,
    "duetorelatedpartiesdeferredrevenuenoncurrent": 9705000,
    "otherliabilitiesnoncurrentduetorelatedparties": 656000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 125000000,
    "preferredstocksharesoutstanding": 42619022,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 225000000,
    "commonstocksharesissued": 98770000,
    "commonstocksharesoutstanding": 98770000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 9649000,
    "costofrevenue": 18848000,
    "typeofcostgoodorserviceextensiblelist": "http://fasb.org/us-gaap/2023#ProductMember",
    "researchanddevelopmentexpense": 282861000,
    "sellinggeneralandadministrativeexpense": 115252000,
    "restructuringcharges": 12606000,
    "costsandexpenses": 429567000,
    "operatingincomeloss": -281815000,
    "interestexpense": 15532000,
    "nonoperatingincomeexpense": 10480000,
    "interestincomeexpensenonoperatingnet": -5052000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -286867000,
    "incometaxexpensebenefit": 3000,
    "incomelossfromequitymethodinvestments": 2638000,
    "netincomeloss": -284232000,
    "earningspersharebasic": -2.92,
    "earningspersharediluted": -2.92,
    "weightedaveragenumberofsharesoutstandingbasic": 97303000,
    "weightedaveragenumberofdilutedsharesoutstanding": 97303000,
    "collaborationservicesandotherrevenue": 6662000,
    "productrevenue": 89055000,
    "drugproductrevenuefromrelatedparty": 18753000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -3712000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 2557000,
    "othercomprehensiveincomelossnetoftax": -1155000,
    "comprehensiveincomenetoftax": -285387000,
    "sharesoutstanding": 98770247,
    "stockissuedduringperiodsharesacquisitions": 520000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 2557000,
    "stockissuedduringperiodvaluenewissues": 24000,
    "stockissuedduringperiodsharesnewissues": 2472090,
    "adjustmentstoadditionalpaidincapitalsharesissuedfromstockplansnetofpayrolltaxespaid": 22000,
    "sharesissuedfromstockplansnetofpayrolltaxespaidshares": 2132071,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 50767000,
    "profitloss": -284232000,
    "depreciation": 9518000,
    "financeleaserightofuseassetamortization": 412000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 5061000,
    "investmentgainlossinunconsolidatedvariableinterestentity": 2638000,
    "gainlossondispositionofassets": -4000,
    "sharebasedcompensation": 50767000,
    "acquiredinprocessresearchanddevelopmentexpenses": 24636000,
    "noncashinterestexpenserelatedtosaleoffuturerevenues": 7734000,
    "dividendreceivedfromunconsolidatedvariableinterestentity": 2255000,
    "impairmentofinvestments": 1000000,
    "debtsecuritiesavailableforsalerealizedgainlossexcludingotherthantemporaryimpairment": -271000,
    "increasedecreaseinaccountsreceivable": -3433000,
    "increasedecreaseininventories": 1695000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 28165000,
    "increasedecreaseinoperatingleaserightofuseassets": -11704000,
    "increasedecreaseinotheroperatingassets": -256000,
    "increasedecreaseinaccountspayable": -15514000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -49778000,
    "increasedecreaseinoperatingleaseliabilitiescurrent": 3820000,
    "increasedecreaseincontractwithcustomerliability": -28166000,
    "increasedecreaseinaccruedinterestforfinanceleaseliabilities": -11000,
    "increasedecreaseinoperatingleaseliabilitiesnoncurrent": -12998000,
    "increasedecreaseinothernoncurrentliabilities": -2573000,
    "netcashprovidedbyusedinoperatingactivities": -315021000,
    "paymentstoacquirepropertyplantandequipment": 2519000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 251830000,
    "cashacquiredfromacquisition": 656000,
    "proceedsfromsalesofavailableforsalesecurities": 6729000,
    "proceedsfromsalematurityandcollectionsofinvestments": 400621000,
    "netcashprovidedbyusedininvestingactivities": 153657000,
    "proceedsfromissuanceofsecureddebt": 74078000,
    "repaymentsofsecureddebt": 2746000,
    "repaymentsoffinanceleaseliabilities": 148000,
    "repaymentsofdebtandcapitalleaseobligations": 336000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 237000,
    "proceedsfromissuanceinitialpublicoffering": 48407000,
    "proceedsfromissuanceofcommonstock": 3731000,
    "netcashprovidedbyusedinfinancingactivities": 122749000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -3397000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -42012000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 113688000,
    "noncashacquisitioninfortis": -22000000,
    "interestpaidnet": 54000,
    "capitalexpendituresincurredbutnotyetpaid": 103000,
    "increasedecreaseinaccountsreceivablerelatedparties": -6009000,
    "increasedecreaseinaccountspayablerelatedparties": -24072000,
    "increasedecreaseindeferredrevenue": -23378000,
    "numberofoperatingsegments": 1,
    "concentrationriskpercentage1": 0.42,
    "highlyliquidinvestmentmaturityperiod": "three months or less",
    "restrictedtimedepositsnoncurrent": 1700000,
    "shortterminvestmentsmaximummaturityperiod": "P12M",
    "longterminvestmentsminimummaturityperiod": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "profitsharepercent": 0.5,
    "revenueperformanceobligationdescriptionofpaymentterms": "The period between the transfer of control of the promised goods and when the Company receives payment is based on 60-day payment terms.",
    "descriptionofsalesreturn": "distributors can request to return product to the Company only due to quality issues or for product purchased within one year prior to the productâ€™s expiration date.",
    "maximumresearchanddevelopmentandregulatorymilestonepaymentsreceivable": 175000000,
    "maximumsalesmilestonesreceivable": 170000000,
    "percentageoftieredroyaltiesreceivable": 0.1,
    "additionalconsiderationbasedonnetsales": "the low 20% range of the list price",
    "collaborativearrangementaggregateconsiderationexcludingdrugproductrevenue": 105100000,
    "supplies": 26481000,
    "contractwithcustomerliabilityrevenuerecognized": 3500000,
    "variableconsiderationpaymentreceivedfromestimatedfuturecodevelopmentbilling": 2300000,
    "proceedsfromnoncontingentupfrontpayments": 40100000,
    "variableconsiderationpaymentreceiveduponachievementofmilestone": 65000000,
    "variableconsiderationpaymentreceivedrelatedtocodevelopmentbillings": 12300000,
    "alternativeinvestmentmeasurementinput": 17.5,
    "collaborativearrangementaggregateconsideration": 77200000,
    "copromotionexpenses": 4600000,
    "contractwithcustomerassetnetcurrent": 4000000,
    "variableconsiderationrelatedtoprofitshare": 7100000,
    "royaltyrateonnetrevenue": 0.4,
    "collaborativearrangementaggregateconsiderationformilestoneandupfrontpayments": 1000000,
    "milestonepayments": 3000000,
    "manufacturingrelatedmilestonepayments": 3000000,
    "cumulativerevenuelicenseanddevelopmentrevenuerecognized": 344493000,
    "contractwithcustomerliability": 179851000,
    "cashconsiderationreceivedundercollaborationagreement": 100347000,
    "suppliesnet": 26500000,
    "revenuegrossfromcontractwithcustomerexcludingassessedtax": 13190000,
    "revenuegrosstransferpricefromcontractwithcustomerexcludingassessedtax": 154817000,
    "allowancefordoubtfulaccountsreceivable": 3000000,
    "contractwithcustomerliabilityincreasedecreaseinrevenueduetochangestoestimatedvariableconsideration": 2900000,
    "contractwithcustomerliabilityadditions": 94099000,
    "contractwithcustomerliabilityincreasedecreasefromcurrenttranslationandother": 839000,
    "contractwithcustomerliabilityreclassifiedtoaccruedliability": 38746000,
    "accruedliabilitiescurrentandnoncurrent": 1200000,
    "equitymethodinvestmentownershippercentage": 0.02,
    "fairvalueoftheacquiredinprocessresearchanddevelopmentassets": 24400000,
    "businessacquisitionpercentageofvotinginterestsacquired": 0.511,
    "investmentincomedividend": 2300000,
    "equitymethodinvestmentincreasedecreasefromcurrencytranslation": -154000,
    "cashandcashequivalentsfairvaluedisclosure": 12288000,
    "availableforsalesecuritiesdebtsecurities": 13992000,
    "assetsfairvaluedisclosure": 55085000,
    "fairvalueassetslevel1tolevel2transferamount": 20400000,
    "lesseefinanceleasetermofcontract1": "P15Y",
    "lesseefinanceleaseexpirationperiod": 2023,
    "financeleaserightofuseasset": 153000,
    "financeleaseliability": 144000,
    "operatingleaseliability": 80614000,
    "operatingleasepayments": 14463000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "lesseeoperatingleaseexpirationperiod": 2026,
    "financeleaserightofuseassetscost": 2478000,
    "financeleaseaccumulatedamortization": 2325000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "operatingleaserightofuseassetscost": 103010000,
    "operatingleaseaccumulatedamortization": 34917000,
    "financeleaseandoperatingleaseassets": 68246000,
    "financeleaseliabilitycurrent": 40000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#LiabilitiesCurrent",
    "financeleaseliabilitynoncurrent": 104000,
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent",
    "financeleaseandoperatingleaseliability": 80758000,
    "financeleaseinterestexpense": 1000,
    "operatingleasecost": 17006000,
    "subleaseincome": 3024000,
    "leasecost": 14395000,
    "financeleaseinterestpaymentonliability": 9000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 131000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1278000,
    "financeleaseweightedaverageremainingleaseterm1": "P3Y10M24D",
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y9M18D",
    "financeleaseweightedaveragediscountratepercent": 0.0617,
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 47000,
    "financeleaseliabilitypaymentsdueyeartwo": 39000,
    "financeleaseliabilitypaymentsdueyearthree": 39000,
    "financeleaseliabilitypaymentsdueyearfour": 37000,
    "financeleaseliabilitypaymentsdue": 162000,
    "financeleaseliabilityundiscountedexcessamount": 18000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 17554000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 18836000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 18082000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 18476000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 17401000,
    "lesseeoperatingleaseliabilitypaymentsdue": 90349000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 9735000,
    "cash": 63396000,
    "commercialpaperatcarryingvalue": 36016000,
    "moneymarketfundsatcarryingvalue": 12288000,
    "usgovernmentsecuritiesatcarryingvalue": 1988000,
    "losscontingencyreceivablecurrent": 28500000,
    "accruedapiandbulkdrugproductpricetrueupcurrent": 50978000,
    "accruedlitigationsettlement": 28500000,
    "paymentsforrestructuring": 8900000,
    "accruedrestructuringcharges": 3700000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 13988000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 9000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 5000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 4984000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 1000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 3495000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 5000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 3495000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 5000,
    "inventoryrawmaterials": 1376000,
    "inventoryworkinprocess": 34614000,
    "inventoryfinishedgoods": 5575000,
    "deferredrevenuesfromassociatedcontracts": -26481000,
    "prepaidexpensecurrent": 6644000,
    "otherassetscurrent": 6711000,
    "propertyplantandequipmentgross": 102109000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 136930000,
    "accruedpreclinicalandclinicaltrialcurrent": 27663000,
    "litigationsettlementcurrent": 28500000,
    "employeerelatedliabilitiescurrent": 20267000,
    "accruedcopromotionexpensescurrent": 10309000,
    "accruedprofitsharecurrent": 7084000,
    "propertytaxesandothercurrent": 6615000,
    "accruedprofessionalfeescurrent": 7103000,
    "liabilityrelatedtosaleoffuturerevenuescurrent": 5654000,
    "accruedrestructuringchargecurrent": 3697000,
    "otheraccruedliabilitiescurrent": 5021000,
    "accruedliabilitiescurrent": 172891000,
    "effectiveannualinterestraterelatedtosaleoffuturerevenues": 0.1603,
    "noncashinterestexpenserelatedtodrugproductrevenue": 7700000,
    "liabilityrelatedtosaleoffuturerevenues": 57067000,
    "liabilityrelatedtosaleofrevenuecurrent": 5654000,
    "liabilityrelatedtosaleofrevenuesnoncurrent": 51413000,
    "longtermdebt": 71934000,
    "debtinstrumentinterestrateduringperiod": 0.1613,
    "debtinstrumentcarryingamount": 75000000,
    "debtinstrumentaccruedinterest": 400000,
    "interestexpensedebt": 7400000,
    "unrestrictedcashandcashequivalentbalancemaintaininaccounts": 30000000,
    "unamortizedissuancecostsandtransactioncosts": -3066000,
    "numberofproductdevelopmentobligations": 11,
    "loansreceivablebasisspreadonvariablerate": 0.01,
    "debtinstrumentinterestratestatedpercentage": 0.03,
    "accruedproductdevelopmentcostsexcludinginterest": 10400000,
    "interestpayablecurrentandnoncurrent": 7300000,
    "recordedunconditionalpurchaseobligationduewithinoneyear": 17995000,
    "recordedunconditionalpurchaseobligationdueinsecondyear": 4827000,
    "recordedunconditionalpurchaseobligation": 22822000,
    "maximumfuturemilestonepayments": 697900000,
    "losscontingencyaccrualatcarryingvalue": 28500000,
    "commonstockvotingrights": "one vote",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11104000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 4404000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 10769000,
    "commonstockcapitalsharesreservedforfutureissuance": 5952000,
    "commonstocksharesreserved": 130999000,
    "weightedaverageofferingpricespershare": 19.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-11-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Option vesting schedules are determined by the Company at the time of issuance and generally have a four year vesting schedule (25% vesting on the first anniversary of the vesting base date and quarterly thereafter over the next 3 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperioddescription": "Shares reserved for issuance increases on January 1 of each year commencing on January 1, 2016 and ending on January 1, 2024 by the lesser of (i) the amount equal to 4% of the number of shares issued and outstanding on December 31 immediately prior to the date of increase or (ii) such lower number of shares as may be determined by the board of directors. As of December 31, 2023, the Company has reserved 10,768,935 shares of its common stock that remains unissued for issuance under the 2014 Plan.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 900000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 1648201,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 4612000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 68541,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 5738000,
    "stockissuedduringperiodsharesstockoptionsexercisedfullyear": 122000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1725000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 1875000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 10224000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4688000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.27,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 12.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 22.49,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 34.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 19.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 30.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M3D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 83000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 68000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 2002000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 1875000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 12.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 14.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 20.58,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 361911,
    "allocatedsharebasedcompensationexpense": 25462000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.928,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.567,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 2.712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.052,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 25600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M21D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 35600000,
    "preferredstockredemptionterms": "Redemption Right â€” If a Preferred Share can be redeemed by a majority shareholder owning more than ninety percent (90%) of the shares of FibroGen Europe in accordance with the provisions of the Finnish Limited Liability Companies Act, the minority holders of Preferred Shares have the right to request redemption of their shares.",
    "requiredminimumshareholderpercentagetocallforredemptionofpreferredshares": 0.9,
    "preferredstockvotingrights": "one vote",
    "convertiblepreferredstocksharesissueduponconversion": 1,
    "preferredsharesissuedpricepershare": 1,
    "preferredstockdividendratepercentage": 0.06,
    "derivativefixedinterestrate": 0.02,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 10596000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -328475000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 41608000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -286867000,
    "currentforeigntaxexpensebenefit": 3000,
    "currentincometaxexpensebenefit": 3000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationdeductionexpensesharebasedcompensationcost": -0.011,
    "effectiveincometaxratereconciliationnetoperatinglossesnotbenefitted": -0.179,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.03,
    "effectiveincometaxratereconciliationdeductions": -0.005,
    "effectiveincometaxratereconciliationgiltipercent": 0.043,
    "effectiveincometaxratereconciliationotheradjustments": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 175257000,
    "deferredtaxassetstaxcreditcarryforwards": 123156000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 48396000,
    "deferredtaxassetstaxcapitalizedresearchanddevelopmentexpenses": 81697000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9155000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 17189000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 5475000,
    "deferredtaxassetsdeferredincome": 24792000,
    "deferredtaxassetsintangibleassets": 63146000,
    "deferredtaxassetsother": 698000,
    "deferredtaxassetsgross": 548961000,
    "deferredtaxassetsvaluationallowance": 534967000,
    "deferredtaxassetsnet": 13994000,
    "deferredtaxliabilitiesfixedassets": 10511000,
    "deferredtaxliabilitiesnondeductibaleaccruedexpenses": -3483000,
    "deferredtaxliabilities": 13994000,
    "valuationallowancedeferredtaxassetchangeinamount": 57000000,
    "operatinglosscarryforwardsexpirationyear": 2026,
    "deferredtaxassetstaxcreditcarryforwardsother": 143300000,
    "othertaxcreditcarryforwardsexpirationyear": 2024,
    "unrecognizedtaxbenefits": 81000000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 600000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleestimatedrangenotpossible": "The Company does not anticipate a material change to its unrecognized tax benefits over the next twelve months that would affect the Companyâ€™s effective tax rate.",
    "opentaxyear": 2014,
    "corporatealternativeminimumtaxpercentage": 0.15,
    "percentageofexcisetaxonstockbuyback": 0.01,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 154000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 8805000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfromforeigncurrencytranslation": -477000,
    "revenues": 6700000,
    "otherliabilities": 40500000,
    "variableinterestentityownershippercentage": 0.511,
    "valuationallowancesandreservesbalance": 534967000,
    "valuationallowancesandreserveschargedtocostandexpense": 56998000,
    "valuationallowancesandreserveschargedtootheraccounts": -849000,
    "valuationallowancesandreservesdeductions": 60964000
  },
  {
    "date": "2022-12-30",
    "symbol": "FGEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "FGEN",
    "entityregistrantname": "FIBROGEN, INC.",
    "entitycentralindexkey": 921299,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-36740",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "77-0357827",
    "entityaddressaddressline1": "409 Illinois Street",
    "entityaddresscityortown": "San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94158,
    "cityareacode": 415,
    "localphonenumber": "978-1200",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "San Jose, California",
    "cashandcashequivalentsatcarryingvalue": 155700000,
    "shortterminvestments": 266308000,
    "accountsreceivablenetcurrent": 16299000,
    "inventorynet": 40436000,
    "prepaidexpenseandotherassetscurrent": 14083000,
    "assetscurrent": 492826000,
    "restrictedcashandcashequivalentsnoncurrent": 2072000,
    "longterminvestmentexcludingequitymethodinvestments": 4348000,
    "propertyplantandequipmentnet": 20605000,
    "equitymethodinvestments": 5061000,
    "operatingleaserightofuseasset": 79893000,
    "otherassetsnoncurrent": 5282000,
    "assets": 610087000,
    "accountspayablecurrent": 30758000,
    "accruedliabilitiesandotherliabilities": 219773000,
    "contractwithcustomerliabilitycurrent": 12739000,
    "operatingleaseliabilitycurrent": 10292000,
    "liabilitiescurrent": 273562000,
    "accruedproductdevelopmentcosts": 16917000,
    "contractwithcustomerliabilitynoncurrent": 185722000,
    "operatingleaseliabilitynoncurrent": 79593000,
    "liabilityrelatedtosaleoffuturerevenuesnoncurrent": 49333000,
    "otherliabilitiesnoncurrent": 6440000,
    "liabilities": 611567000,
    "commonstockvalue": 942000,
    "additionalpaidincapital": 1541019000,
    "accumulatedothercomprehensiveincomelossnetoftax": -5720000,
    "retainedearningsaccumulateddeficit": -1557688000,
    "stockholdersequity": -21447000,
    "minorityinterest": 19967000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -1480000,
    "liabilitiesandstockholdersequity": 610087000,
    "accountsreceivablerelatedpartiescurrent": 12088000,
    "duetorelatedpartiescurrent": 63886000,
    "duetorelatedpartiesdeferredrevenuecurrent": 9259000,
    "duetorelatedpartiesdeferredrevenuenoncurrent": 31044000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 125000000,
    "preferredstocksharesoutstanding": 42619022,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 225000000,
    "commonstocksharesissued": 94166000,
    "commonstocksharesoutstanding": 94166000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 22590000,
    "costofrevenue": 20280000,
    "typeofcostgoodorserviceextensiblelist": "http://fasb.org/us-gaap/2022#ProductMember",
    "researchanddevelopmentexpense": 296791000,
    "sellinggeneralandadministrativeexpense": 124688000,
    "costsandexpenses": 441759000,
    "operatingincomeloss": -301025000,
    "interestexpense": 1440000,
    "nonoperatingincomeexpense": 7596000,
    "interestincomeexpensenonoperatingnet": 6156000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -294869000,
    "incometaxexpensebenefit": 358000,
    "incomelossfromequitymethodinvestments": 1573000,
    "netincomeloss": -293654000,
    "earningspersharebasic": -3.14,
    "earningspersharediluted": -3.14,
    "weightedaveragenumberofsharesoutstandingbasic": 93582000,
    "weightedaveragenumberofdilutedsharesoutstanding": 93582000,
    "licensefeesandmilestonesrevenue": 22590000,
    "collaborationservicesandotherrevenue": 9908000,
    "productrevenue": 71167000,
    "drugproductrevenuefromrelatedparty": 11086000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 75000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1632000,
    "othercomprehensiveincomelossnetoftax": -1557000,
    "comprehensiveincomenetoftax": -295211000,
    "sharesoutstanding": 94166086,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -1632000,
    "adjustmentstoadditionalpaidincapitalsharesissuedfromstockplansnetofpayrolltaxespaid": 13000,
    "sharesissuedfromstockplansnetofpayrolltaxespaidshares": 1285553,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 65601000,
    "profitloss": -293654000,
    "depreciation": 10017000,
    "financeleaserightofuseassetamortization": 587000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -1619000,
    "investmentgainlossinunconsolidatedvariableinterestentity": 1573000,
    "gainlossondispositionofassets": 1000,
    "sharebasedcompensation": 65601000,
    "noncashinterestexpenserelatedtosaleoffuturerevenues": 1036000,
    "debtsecuritiesavailableforsalerealizedgainlossexcludingotherthantemporaryimpairment": -5000,
    "increasedecreaseinaccountsreceivable": -765000,
    "increasedecreaseininventories": 10999000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -4916000,
    "increasedecreaseinoperatingleaserightofuseassets": -10908000,
    "increasedecreaseinotheroperatingassets": -263000,
    "increasedecreaseinaccountspayable": 5909000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 90556000,
    "increasedecreaseinoperatingleaseliabilitiescurrent": -547000,
    "increasedecreaseincontractwithcustomerliability": -4130000,
    "increasedecreaseinaccruedinterestforfinanceleaseliabilities": 33000,
    "increasedecreaseinoperatingleaseliabilitiesnoncurrent": -8994000,
    "increasedecreaseinothernoncurrentliabilities": -18250000,
    "netcashprovidedbyusedinoperatingactivities": -145933000,
    "paymentstoacquirepropertyplantandequipment": 3741000,
    "paymentstoacquireinprocessresearchanddevelopment": 35000000,
    "proceedsfromsaleofpropertyplantandequipment": 6000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 164023000,
    "proceedsfromsalesofavailableforsalesecurities": 7382000,
    "proceedsfromsalematurityandcollectionsofinvestments": 284492000,
    "netcashprovidedbyusedininvestingactivities": 89116000,
    "repaymentsoffinanceleaseliabilities": 135000,
    "repaymentsofdebtandcapitalleaseobligations": 403000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 5167000,
    "proceedsfromsaleoffuturerevenuesnetofissuancecosts": 49750000,
    "paymentsfortransactioncostsrelatedtosaleoffuturerevenues": 1453000,
    "proceedsfromissuanceofcommonstock": 4184000,
    "netcashprovidedbyusedinfinancingactivities": 46776000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -5482000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -15523000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 155700000,
    "interestpaidnet": 104000,
    "capitalexpendituresincurredbutnotyetpaid": 428000,
    "increasedecreaseinaccountsreceivablerelatedparties": -1158000,
    "increasedecreaseinaccountspayablerelatedparties": 63882000,
    "increasedecreaseindeferredrevenue": 11211000,
    "numberofoperatingsegments": 1,
    "concentrationriskpercentage1": 0.65,
    "highlyliquidinvestmentmaturityperiod": "three months or less",
    "restrictedtimedepositsnoncurrent": 2100000,
    "shortterminvestmentsmaximummaturityperiod": "P12M",
    "longterminvestmentsminimummaturityperiod": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "profitsharepercent": 0.5,
    "revenueperformanceobligationdescriptionofpaymentterms": "The period between the transfer of control of the promised goods and when the Company receives payment is based on 60-day payment terms.",
    "descriptionofsalesreturn": "Distributors can request to return product to the Company only due to quality issues or for product purchased within one year prior to the productâ€™s expiration date.",
    "additionalconsiderationbasedonnetsales": "the low 20% range of the list price",
    "collaborativearrangementaggregateconsiderationexcludingdrugproductrevenue": 105100000,
    "revenuefromrelatedparties": 32500000,
    "supplies": 17488000,
    "contractwithcustomerliabilityrevenuerecognized": 2300000,
    "proceedsfromnoncontingentupfrontpayments": 40100000,
    "variableconsiderationpaymentreceiveduponachievementofmilestone": 65000000,
    "variableconsiderationpaymentreceivedrelatedtocodevelopmentbillings": 12100000,
    "alternativeinvestmentmeasurementinput": 17.5,
    "collaborativearrangementaggregateconsideration": 77200000,
    "copromotionexpenses": 4400000,
    "variableconsiderationrelatedtoprofitshare": 7300000,
    "royaltyrateonnetrevenue": 0.4,
    "cumulativerevenuelicenseanddevelopmentrevenuerecognized": 100347000,
    "contractwithcustomerliability": 175646000,
    "cashconsiderationreceivedundercollaborationagreement": 100347000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 25000000,
    "variableconsiderationpaymentreceivedfromestimatedfuturecodevelopmentbilling": 5000000,
    "suppliesnet": 17500000,
    "revenuegrossfromcontractwithcustomerexcludingassessedtax": 12366000,
    "revenuegrosstransferpricefromcontractwithcustomerexcludingassessedtax": 112544000,
    "allowancefordoubtfulaccountsreceivable": 500000,
    "contractwithcustomerliabilityincreasedecreaseinrevenueduetochangestoestimatedvariableconsideration": 1400000,
    "contractwithcustomerliabilityadditions": 653000,
    "contractwithcustomerliabilitydeduction": 3222000,
    "contractwithcustomerliabilityincreasedecreasefromcurrenttranslationandother": 217000,
    "contractwithcustomerliabilityreclassifiedtoaccruedliability": 4200000,
    "billedcontractreceivables": 49200000,
    "accruedliabilitiescurrentandnoncurrent": 6500000,
    "businessacquisitionpercentageofvotinginterestsacquired": 0.511,
    "equitymethodinvestmentownershippercentage": 0.511,
    "equitymethodinvestmentincreasedecreasefromcurrencytranslation": -337000,
    "cashandcashequivalentsfairvaluedisclosure": 19881000,
    "availableforsalesecuritiesdebtsecurities": 82008000,
    "assetsfairvaluedisclosure": 118853000,
    "fairvalueassetslevel1tolevel2transferamount": 10500000,
    "lesseefinanceleasetermofcontract1": "P15Y",
    "lesseefinanceleaseexpirationperiod": 2023,
    "financeleaserightofuseasset": 435000,
    "financeleaseliability": 173000,
    "operatingleaseliability": 89885000,
    "operatingleasepayments": 15497000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "lesseeoperatingleaseexpirationperiod": 2025,
    "financeleaserightofuseassetscost": 2367000,
    "financeleaseaccumulatedamortization": 1932000,
    "financeleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "operatingleaserightofuseassetscost": 101990000,
    "operatingleaseaccumulatedamortization": 22097000,
    "financeleaseandoperatingleaseassets": 80328000,
    "financeleaseliabilitycurrent": 36000,
    "financeleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#LiabilitiesCurrent",
    "financeleaseliabilitynoncurrent": 137000,
    "financeleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent",
    "financeleaseandoperatingleaseliability": 90058000,
    "operatingleasecost": 17125000,
    "subleaseincome": 3373000,
    "leasecost": 14339000,
    "financeleaseinterestpaymentonliability": 2000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 261000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1704000,
    "financeleaseweightedaverageremainingleaseterm1": "P4Y10M24D",
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y9M18D",
    "financeleaseweightedaveragediscountratepercent": 0.062,
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 44000,
    "financeleaseliabilitypaymentsdueyeartwo": 41000,
    "financeleaseliabilitypaymentsdueyearthree": 40000,
    "financeleaseliabilitypaymentsdueyearfour": 39000,
    "financeleaseliabilitypaymentsdueyearfive": 36000,
    "financeleaseliabilitypaymentsdue": 200000,
    "financeleaseliabilityundiscountedexcessamount": 27000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 13915000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 17302000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 18448000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 18000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 18476000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 17400000,
    "lesseeoperatingleaseliabilitypaymentsdue": 103541000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 13656000,
    "cash": 135819000,
    "moneymarketfundsatcarryingvalue": 19881000,
    "accruedapiandbulkdrugproductpricetrueupcurrent": 75055000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 83080000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 5000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1072000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 6738000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 147000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 75270000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 925000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 82008000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 1072000,
    "inventoryrawmaterials": 1241000,
    "inventoryworkinprocess": 36003000,
    "inventoryfinishedgoods": 3192000,
    "deferredrevenuesfromassociatedcontracts": -17488000,
    "prepaidexpensecurrent": 9730000,
    "otherassetscurrent": 4353000,
    "propertyplantandequipmentgross": 102580000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 128682000,
    "accruedpreclinicalandclinicaltrialcurrent": 57780000,
    "employeerelatedliabilitiescurrent": 22562000,
    "accruedcopromotionexpensescurrent": 36677000,
    "accruedcontractliabilitiestopharmaceuticaldistributorscurrent": 390000,
    "accruedprofitsharecurrent": 7280000,
    "propertytaxesandothercurrent": 7691000,
    "accruedprofessionalfeescurrent": 5480000,
    "otheraccruedliabilitiescurrent": 6858000,
    "accruedliabilitiescurrent": 219773000,
    "effectiveannualinterestraterelatedtosaleoffuturerevenues": 0.1967,
    "noncashinterestexpenserelatedtodrugproductrevenue": 1000000,
    "revenuepaymentcapamount": 125000000,
    "liabilityrelatedtosaleoffuturerevenues": 49333000,
    "grossproceedsfromsaleoffuturerevenues": 50000000,
    "initialissuancecostsrelatedtosaleoffuturerevenues": -250000,
    "transactioncostsrelatedtosaleoffuturerevenues": -1453000,
    "liabilityrelatedtosaleofrevenuesnoncurrent": 49333000,
    "numberofproductdevelopmentobligations": 11,
    "loansreceivablebasisspreadonvariablerate": 0.01,
    "debtinstrumentinterestratestatedpercentage": 0.03,
    "accruedproductdevelopmentcostsexcludinginterest": 10100000,
    "interestpayablecurrentandnoncurrent": 6800000,
    "recordedunconditionalpurchaseobligationduewithinoneyear": 85000,
    "recordedunconditionalpurchaseobligationdueinsecondyear": 22310000,
    "recordedunconditionalpurchaseobligation": 22395000,
    "maximumfuturemilestonepayments": 697900000,
    "commonstockvotingrights": "one vote",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9088000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 3669000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 11524000,
    "commonstockcapitalsharesreservedforfutureissuance": 5373000,
    "commonstocksharesreserved": 123820000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-11-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Option vesting schedules are determined by the Company at the time of issuance and generally have a four year vesting schedule (25% vesting on the first anniversary of the vesting base date and quarterly thereafter over the next 3 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperioddescription": "Shares reserved for issuance increases on January 1 of each year commencing on January 1, 2016 and ending on January 1, 2024 by the lesser of (i) the amount equal to 4% of the number of shares issued and outstanding on December 31 immediately prior to the date of increase or (ii) such lower number of shares as may be determined by the board of directors. As of December 31, 2022, the Company has reserved 11,523,829 shares of its common stock that remains unissued for issuance under the 2014 Plan.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1438000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 779539,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 3151000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2902000,
    "stockissuedduringperiodsharesstockoptionsexercisedfullyear": 179000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 1847000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 755000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8614000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4730000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 29.19,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.72,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 34.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 32.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 29.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 35.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y11M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y5M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 5770000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1142000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 644000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 27.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 25.06,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 327298,
    "allocatedsharebasedcompensationexpense": 34861000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.668,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.585,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.976,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.022,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.045,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 40800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y5M4D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 46900000,
    "preferredstockredemptionterms": "Redemption Right â€” If a Preferred Share can be redeemed by a majority shareholder owning more than ninety percent (90%) of the shares of FibroGen Europe in accordance with the provisions of the Finnish Limited Liability Companies Act, the minority holders of Preferred Shares have the right to request redemption of their shares.",
    "requiredminimumshareholderpercentagetocallforredemptionofpreferredshares": 0.9,
    "preferredstockvotingrights": "one vote",
    "convertiblepreferredstocksharesissueduponconversion": 1,
    "preferredsharesissuedpricepershare": 1,
    "preferredstockdividendratepercentage": 0.06,
    "derivativefixedinterestrate": 0.02,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9520000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -307056000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 12187000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -294869000,
    "currentforeigntaxexpensebenefit": 358000,
    "currentincometaxexpensebenefit": 358000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationdeductionexpensesharebasedcompensationcost": -0.025,
    "effectiveincometaxratereconciliationnetoperatinglossesnotbenefitted": -0.163,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.009,
    "effectiveincometaxratereconciliationdeductions": -0.002,
    "effectiveincometaxratereconciliationgiltipercent": 0.028,
    "effectiveincometaxratereconciliationotheradjustments": -0.002,
    "effectiveincometaxratecontinuingoperations": -0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 166708000,
    "deferredtaxassetstaxcreditcarryforwards": 106131000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 49990000,
    "deferredtaxassetstaxcapitalizedresearchanddevelopmentexpenses": 45125000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8616000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 18442000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 4929000,
    "deferredtaxassetsdeferredincome": 21624000,
    "deferredtaxassetsintangibleassets": 69159000,
    "deferredtaxassetsother": 1277000,
    "deferredtaxassetsgross": 492001000,
    "deferredtaxassetsvaluationallowance": 477969000,
    "deferredtaxassetsnet": 14032000,
    "deferredtaxliabilitiesfixedassets": 13101000,
    "deferredtaxliabilitiesnondeductibaleaccruedexpenses": -931000,
    "deferredtaxliabilities": 14032000,
    "valuationallowancedeferredtaxassetchangeinamount": 68200000,
    "operatinglosscarryforwardsexpirationyear": 2026,
    "deferredtaxassetstaxcreditcarryforwardsother": 121600000,
    "othertaxcreditcarryforwardsexpirationyear": 2023,
    "unrecognizedtaxbenefits": 72800000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 700000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleestimatedrangenotpossible": "The Company does not anticipate a material change to its unrecognized tax benefits over the next twelve months that would affect the Companyâ€™s effective tax rate.",
    "opentaxyear": 2013,
    "corporatealternativeminimumtaxpercentage": 0.15,
    "percentageofexcisetaxonstockbuyback": 0.01,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 6954000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 9074000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfromforeigncurrencytranslation": -908000,
    "variableinterestentityownershippercentage": 0.511,
    "revenues": 84631000,
    "valuationallowancesandreservesbalance": 477969000,
    "valuationallowancesandreserveschargedtocostandexpense": 68159000,
    "valuationallowancesandreserveschargedtootheraccounts": 1050000,
    "valuationallowancesandreservesdeductions": 53226000
  },
  {
    "date": "2021-12-30",
    "symbol": "FGEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "FGEN",
    "entityregistrantname": "FIBROGEN, INC.",
    "entitycentralindexkey": 921299,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-36740",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "77-0357827",
    "entityaddressaddressline1": "409 Illinois Street",
    "entityaddresscityortown": "San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94158,
    "cityareacode": 415,
    "localphonenumber": "978-1200",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "San Jose, California",
    "cashandcashequivalentsatcarryingvalue": 171223000,
    "shortterminvestments": 233967000,
    "accountsreceivablenetcurrent": 17401000,
    "inventorynet": 31015000,
    "prepaidexpenseandotherassetscurrent": 20453000,
    "assetscurrent": 474059000,
    "restrictedcashandcashequivalentsnoncurrent": 2072000,
    "longterminvestmentexcludingequitymethodinvestments": 167796000,
    "propertyplantandequipmentnet": 28277000,
    "financeleaserightofuseasset": 761000,
    "equitymethodinvestments": 3825000,
    "operatingleaserightofuseasset": 91112000,
    "otherassetsnoncurrent": 5919000,
    "assets": 773821000,
    "accountspayablecurrent": 26097000,
    "accruedliabilitiesandotherliabilities": 172588000,
    "contractwithcustomerliabilitycurrent": 15857000,
    "financeleaseliabilitycurrent": 11000,
    "operatingleaseliabilitycurrent": 10944000,
    "liabilitiescurrent": 225497000,
    "accruedproductdevelopmentcosts": 17613000,
    "contractwithcustomerliabilitynoncurrent": 186801000,
    "financeleaseliabilitynoncurrent": 3000,
    "operatingleaseliabilitynoncurrent": 88776000,
    "otherliabilitiesnoncurrent": 26018000,
    "liabilities": 544708000,
    "commonstockvalue": 929000,
    "additionalpaidincapital": 1476414000,
    "accumulatedothercomprehensiveincomelossnetoftax": -4163000,
    "retainedearningsaccumulateddeficit": -1264034000,
    "stockholdersequity": 209146000,
    "minorityinterest": 19967000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 229113000,
    "liabilitiesandstockholdersequity": 773821000,
    "accountsreceivablerelatedpartiescurrent": 10930000,
    "duetorelatedpartiescurrent": 4000,
    "duetorelatedpartiesdeferredrevenuecurrent": 3201000,
    "duetorelatedpartiesdeferredrevenuenoncurrent": 25891000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 125000000,
    "preferredstocksharesoutstanding": 42619022,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 225000000,
    "commonstocksharesissued": 92881000,
    "commonstocksharesoutstanding": 92881000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 116434000,
    "costofrevenue": 12871000,
    "typeofcostgoodorserviceextensiblelist": "http://fasb.org/us-gaap/2021-01-31#ProductMember",
    "researchanddevelopmentexpense": 387043000,
    "sellinggeneralandadministrativeexpense": 123925000,
    "costsandexpenses": 523839000,
    "operatingincomeloss": -288530000,
    "interestexpense": 1075000,
    "nonoperatingincomeexpense": -1078000,
    "interestincomeexpensenonoperatingnet": -2153000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -290683000,
    "incometaxexpensebenefit": 347000,
    "incomelossfromequitymethodinvestments": 1007000,
    "netincomeloss": -290023000,
    "earningspersharebasicanddiluted": -3.14,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 92349000,
    "licensefeesandmilestonesrevenue": 108434000,
    "collaborationservicesandotherrevenue": 21928000,
    "productrevenue": 35568000,
    "drugproductrevenuefromrelatedparty": 3186000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 1235000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -899000,
    "othercomprehensiveincomelossnetoftax": 336000,
    "comprehensiveincomenetoftax": -289687000,
    "sharesoutstanding": 92880533,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -899000,
    "adjustmentstoadditionalpaidincapitalsharesissuedfromstockplansnetofpayrolltaxespaid": 15000,
    "sharesissuedfromstockplansnetofpayrolltaxespaidshares": 1439900,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 71161000,
    "conversionofsubsidiarysconvertiblenotepayable": 696000,
    "profitloss": -290023000,
    "depreciation": 10170000,
    "financeleaserightofuseassetamortization": 4639000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -2482000,
    "unrealizedlossgainonequityinvestments": -30000,
    "investmentgainlossinunconsolidatedvariableinterestentity": 1007000,
    "gainlossondispositionofassets": -233000,
    "sharebasedcompensation": 71161000,
    "researchanddevelopmentinprocess": 60000000,
    "increasedecreaseinaccountsreceivable": -25180000,
    "increasedecreaseininventories": 14158000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 9854000,
    "increasedecreaseinoperatingleaserightofuseassets": -4209000,
    "increasedecreaseinotheroperatingassets": 4412000,
    "increasedecreaseinaccountspayable": 805000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 16380000,
    "increasedecreaseinoperatingleaseliabilitiescurrent": 503000,
    "increasedecreaseincontractwithcustomerliability": 57637000,
    "increasedecreaseinaccruedinterestforfinanceleaseliabilities": -75000,
    "increasedecreaseinoperatingleaseliabilitiesnoncurrent": -4043000,
    "increasedecreaseinothernoncurrentliabilities": -12089000,
    "netcashprovidedbyusedinoperatingactivities": -82232000,
    "paymentstoacquirepropertyplantandequipment": 5186000,
    "paymentstoacquireinprocessresearchanddevelopment": 25000000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 484144000,
    "proceedsfromsalesofavailableforsalesecurities": 4214000,
    "proceedsfromsalematurityandcollectionsofinvestments": 83144000,
    "netcashprovidedbyusedininvestingactivities": -426972000,
    "repaymentsoffinanceleaseliabilities": 5489000,
    "repaymentsofdebtandcapitalleaseobligations": 403000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 7372000,
    "proceedsfromissuanceofcommonstock": 12701000,
    "netcashprovidedbyusedinfinancingactivities": -563000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 2597000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -507170000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 171223000,
    "interestpaidnet": 94000,
    "capitalexpendituresincurredbutnotyetpaid": 1009000,
    "constructioninprogressexpendituresincurredbutnotyetpaid": 35000000,
    "balanceinotherreceivablesrelatedtostockoptionexercise": 165000,
    "conversionofsubsidiarysconvertiblenotepayabletononcontrollinginterests": 696000,
    "increasedecreaseinaccountsreceivablerelatedparties": -6803000,
    "increasedecreaseinprepaidexpensesandothercurrentassetsrelatedparties": 889000,
    "increasedecreaseinaccountspayablefromrelatedparty": -1118000,
    "increasedecreaseinaccountspayablerelatedparties": -20000,
    "increasedecreaseindeferredrevenue": 21549000,
    "numberofoperatingsegments": 1,
    "concentrationriskpercentage1": 0.63,
    "highlyliquidinvestmentmaturityperiod": "three months or less",
    "restrictedtimedepositsnoncurrent": 2100000,
    "shortterminvestmentsmaximummaturityperiod": "P12M",
    "longterminvestmentsminimummaturityperiod": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "profitsharepercent": 0.5,
    "revenueperformanceobligationdescriptionofpaymentterms": "The period between the transfer of control of the promised goods and when the Company receives payment is based on 60-day payment terms.",
    "descriptionofsalesreturn": "Distributors can request to return product to the Company only due to quality issues or for product purchased within one year prior to the productâ€™s expiration date.",
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinestimateoftransactionprice": 88800000,
    "initialupfrontpayment": 35000000,
    "additionalconsiderationbasedonnetsales": "the low 20% range of the list price",
    "collaborativearrangementaggregateconsiderationexcludingdrugproductrevenue": 105100000,
    "revenuefromrelatedparties": 130400000,
    "supplies": 49800000,
    "contractwithcustomerliabilityrevenuerecognized": 35568000,
    "manufacturingcosts": 1000000,
    "proceedsfromnoncontingentupfrontpayments": 40100000,
    "variableconsiderationpaymentreceiveduponachievementofmilestone": 65000000,
    "variableconsiderationpaymentreceivedrelatedtocodevelopmentbillings": 11900000,
    "alternativeinvestmentmeasurementinput": 17.5,
    "codevelopmentservicesrelatedtockdcontinuedoverdevelopmentperiod": "2021-08",
    "collaborativearrangementaggregateconsideration": 77200000,
    "copromotionexpenses": 4700000,
    "variableconsiderationrelatedtoprofitshare": 7000000,
    "royaltyrateonnetrevenue": 0.4,
    "codevelopmentservicesrelatedtocdkcontinuedoverdevelopmentyear": 2024,
    "collaborativearrangementaggregateconsiderationformilestoneandupfrontpayments": 8000000,
    "cumulativerevenuelicenseanddevelopmentrevenuerecognized": 100347000,
    "contractwithcustomerliability": 171516000,
    "cashconsiderationreceivedundercollaborationagreement": 100347000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 1000000,
    "variableconsiderationpaymentreceivedfromestimatedfuturecodevelopmentbilling": 12900000,
    "suppliesnet": 9100000,
    "revenuegrossfromcontractwithcustomerexcludingassessedtax": 13727000,
    "revenuegrosstransferpricefromcontractwithcustomerexcludingassessedtax": 97531000,
    "allowancefordoubtfulaccountsreceivable": 13400000,
    "contractwithcustomerliabilityadditions": 1371000,
    "contractwithcustomerliabilitydeduction": 13645000,
    "contractwithcustomerliabilityincreasedecreasefromcurrenttranslationandother": -313000,
    "contractwithcustomerliabilitynetofbalancepresentedagainstcontractasset": 49788000,
    "businessacquisitionpercentageofvotinginterestsacquired": 0.511,
    "equitymethodinvestmentownershippercentage": 0.511,
    "equitymethodinvestmentincreasedecreasefromcurrencytranslation": 90000,
    "cashandcashequivalentsfairvaluedisclosure": 58801000,
    "availableforsalesecuritiesdebtsecurities": 182646000,
    "assetsfairvaluedisclosure": 150323000,
    "lesseefinanceleasetermofcontract1": "P15Y",
    "lesseefinanceleaseexpirationperiod": 2023,
    "financeleaseliability": 14000,
    "operatingleaseliability": 99720000,
    "operatingleasepayments": 7900000,
    "lesseeoperatingleasetermofcontract": "P1Y",
    "lesseeoperatingleaseexpirationperiod": 2023,
    "financeleaserightofuseassetscost": 2165000,
    "financeleaseaccumulatedamortization": 1404000,
    "operatingleaserightofuseassetscost": 100912000,
    "operatingleaseaccumulatedamortization": 9800000,
    "financeleaseandoperatingleaseassets": 91873000,
    "financeleaseandoperatingleaseliability": 99734000,
    "financeleaseinterestexpense": 628000,
    "operatingleasecost": 10722000,
    "subleaseincome": 1271000,
    "leasecost": 14718000,
    "financeleaseinterestpaymentonliability": 629000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 450000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3585000,
    "financeleaseweightedaverageremainingleaseterm1": "P1Y1M6D",
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y9M18D",
    "financeleaseweightedaveragediscountratepercent": 0.0464,
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 12000,
    "financeleaseliabilitypaymentsdueyeartwo": 3000,
    "financeleaseliabilitypaymentsdue": 15000,
    "financeleaseliabilityundiscountedexcessamount": 1000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 15387000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 13469000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 16810000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 18205000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 18005000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 35877000,
    "lesseeoperatingleaseliabilitypaymentsdue": 117753000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 18033000,
    "cash": 111422000,
    "commercialpaperatcarryingvalue": 1000000,
    "moneymarketfundsatcarryingvalue": 58801000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 183136000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 2000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 492000,
    "availableforsalesecuritiesbondandmutualfundsmaturingwithinoneyear": 233967000,
    "availableforsalesecuritiesbondandmutualfundsmaturingafteroneyearthroughthreeyears": 167796000,
    "percentageofprelaunchinventorycapitalizedofaggregateinventorybalance": 0.38,
    "transferpricetrueup": 49800000,
    "acquiredinprocessresearchanddevelopmentasset": 35000000,
    "inventoryrawmaterials": 1363000,
    "inventoryworkinprocess": 21499000,
    "inventoryfinishedgoods": 8153000,
    "prepaidexpensecurrent": 7383000,
    "otherassetscurrent": 5070000,
    "propertyplantandequipmentgross": 103352000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 121008000,
    "accruedpreclinicalandclinicaltrialcurrent": 56283000,
    "employeerelatedliabilitiescurrent": 20909000,
    "accruedcontractliabilitiestopharmaceuticaldistributorscurrent": 3176000,
    "accruedcopromotionexpensescurrent": 25746000,
    "accruedprofitsharecurrent": 7895000,
    "propertytaxesandothercurrent": 12610000,
    "accruedprofessionalfeescurrent": 6074000,
    "otheraccruedliabilitiescurrent": 4895000,
    "accruedliabilitiescurrent": 172588000,
    "accruedlongtermcopromotionliabilitynoncurrent": 15236000,
    "deferredtaxandotherliabilitiesnoncurrent": 9192000,
    "othersundryliabilitiesnoncurrent": 1590000,
    "numberofproductdevelopmentobligations": 11,
    "loansreceivablebasisspreadonvariablerate": 0.01,
    "debtinstrumentinterestratestatedpercentage": 0.03,
    "accruedproductdevelopmentcostsexcludinginterest": 10700000,
    "interestpayablecurrentandnoncurrent": 6900000,
    "recordedunconditionalpurchaseobligationduewithinoneyear": 25480000,
    "recordedunconditionalpurchaseobligationdueinsecondyear": 19918000,
    "recordedunconditionalpurchaseobligation": 45398000,
    "maximumfuturemilestonepayments": 704100000,
    "commonstockvotingrights": "one vote",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8967000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2304000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 10253000,
    "commonstockcapitalsharesreservedforfutureissuance": 4771000,
    "commonstocksharesreserved": 119176000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-11-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Option vesting schedules are determined by the Company at the time of issuance and generally have a four year vesting schedule (25% vesting on the first anniversary of the vesting base date and quarterly thereafter over the next 3 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperioddescription": "Shares reserved for issuance increases on JanuaryÂ 1 of each year commencing on JanuaryÂ 1, 2016 and ending on JanuaryÂ 1, 2024 by the lesser of (i)Â the amount equal to 4% of the number of shares issued and outstanding on DecemberÂ 31 immediately prior to the date of increase or (ii)Â such lower number of shares as may be determined by the board of directors. As of DecemberÂ 31, 2021, the Company has reserved 10,252,944 shares of its common stock that remains unissued for issuance under the 2014 Plan.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1408000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 538607,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 30.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3452000,
    "stockissuedduringperiodsharesstockoptionsexercisedfullyear": 688000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 1259000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1828000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8535000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5241000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 34.84,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 35.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 13.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 35.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 34.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 34.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 32.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y4M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y3M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y9M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2622000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 2460000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1808000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 828000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 569000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 30.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 37.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 42.28,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 213505,
    "allocatedsharebasedcompensationexpense": 40547000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.619,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.471,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.022,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 20.21,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 56400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M25D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 52300000,
    "preferredstockredemptionterms": "Redemption Right â€” If a Preferred Share can be redeemed by a majority shareholder owning more than ninety percent (90%)Â of the shares of FibroGen Europe in accordance with the provisions of the Finnish Limited Liability Companies Act, the minority holders of Preferred Shares have the right to request redemption of their shares.",
    "requiredminimumshareholderpercentagetocallforredemptionofpreferredshares": 0.9,
    "preferredstockvotingrights": "one vote",
    "convertiblepreferredstocksharesissueduponconversion": 1,
    "preferredsharesissuedpricepershare": 1,
    "preferredstockdividendratepercentage": 0.06,
    "convertibledebt": 700000,
    "derivativefixedinterestrate": 0.02,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8461000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -268499000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -22184000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -290683000,
    "currentforeigntaxexpensebenefit": 347000,
    "currentincometaxexpensebenefit": 347000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationdeductionexpensesharebasedcompensationcost": -0.018,
    "effectiveincometaxratereconciliationnetoperatinglossesnotbenefitted": -0.168,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.016,
    "effectiveincometaxratereconciliationdeductions": -0.003,
    "effectiveincometaxratereconciliationotheradjustments": -0.006,
    "effectiveincometaxratecontinuingoperations": -0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 167135000,
    "deferredtaxassetstaxcreditcarryforwards": 78832000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 38117000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 10050000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 20415000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 6067000,
    "deferredtaxassetsdeferredincome": 20101000,
    "deferredtaxassetsintangibleassets": 84625000,
    "deferredtaxassetsother": 825000,
    "deferredtaxassetsgross": 426167000,
    "deferredtaxassetsvaluationallowance": 409810000,
    "deferredtaxassetsnet": 16357000,
    "deferredtaxliabilitiesfixedassets": 16357000,
    "deferredtaxliabilities": 16357000,
    "valuationallowancedeferredtaxassetchangeinamount": 72000000,
    "operatinglosscarryforwardsexpirationyear": 2026,
    "deferredtaxassetstaxcreditcarryforwardsother": 87800000,
    "othertaxcreditcarryforwardsexpirationyear": 2022,
    "unrecognizedtaxbenefits": 57700000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 700000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleestimatedrangenotpossible": "The Company does not anticipate a material change to its unrecognized tax benefits over the next twelve months that would affect the Companyâ€™s effective tax rate.",
    "opentaxyear": 2012,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 245000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 8415000,
    "unrecognizedtaxbenefitsincreasesresultingfromforeigncurrencytranslation": 927000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 200000,
    "variableinterestentityownershippercentage": 0.511,
    "revenues": 131243000,
    "valuationallowancesandreservesbalance": 409810000,
    "valuationallowancesandreserveschargedtocostandexpense": 71986000,
    "valuationallowancesandreserveschargedtootheraccounts": -734000,
    "valuationallowancesandreservesdeductions": 29629000
  },
  {
    "date": "2020-12-30",
    "symbol": "FGEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "FGEN",
    "entityregistrantname": "FIBROGEN, INC.",
    "entitycentralindexkey": 921299,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-36740",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "77-0357827",
    "entityaddressaddressline1": "409 Illinois Street",
    "entityaddresscityortown": "San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94158,
    "cityareacode": 415,
    "localphonenumber": "978-1200",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 678393000,
    "shortterminvestments": 8144000,
    "accountsreceivablenetcurrent": 41883000,
    "inventorynet": 16530000,
    "prepaidexpenseandotherassetscurrent": 10160000,
    "assetscurrent": 755110000,
    "restrictedtimedepositsnoncurrent": 2072000,
    "longterminvestments": 244000,
    "propertyplantandequipmentnet": 33647000,
    "financeleaserightofuseasset": 29606000,
    "equitymethodinvestmentinunconsolidatedvariableinterestentity": 2728000,
    "otherassetsnoncurrent": 3433000,
    "assets": 826840000,
    "accountspayablecurrent": 24789000,
    "accruedliabilitiesandotherliabilities": 119521000,
    "contractwithcustomerliabilitycurrent": 6547000,
    "financeleaseliabilitycurrent": 12330000,
    "liabilitiescurrent": 163187000,
    "accruedproductdevelopmentcosts": 18697000,
    "contractwithcustomerliabilitynoncurrent": 138474000,
    "financeleaseliabilitynoncurrent": 25391000,
    "otherliabilitiesnoncurrent": 39642000,
    "liabilities": 385391000,
    "commonstockvalue": 914000,
    "additionalpaidincapital": 1399774000,
    "accumulatedothercomprehensiveincomelossnetoftax": -4499000,
    "retainedearningsaccumulateddeficit": -974011000,
    "stockholdersequity": 422178000,
    "minorityinterest": 19271000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 441449000,
    "liabilitiesandstockholdersequity": 826840000,
    "accountsreceivablerelatedpartiescurrent": 4127000,
    "duefromrelatedpartiescurrent": 889000,
    "accountspayablerelatedpartiescurrent": 1118000,
    "duetorelatedpartiescurrent": 24000,
    "duetorelatedpartiesdeferredrevenuecurrent": 2907000,
    "duetorelatedpartiesdeferredrevenuenoncurrent": 4636000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 125000000,
    "preferredstocksharesoutstanding": 42619022,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 225000000,
    "commonstocksharesissued": 91441000,
    "commonstocksharesoutstanding": 91441000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 14323000,
    "costofgoodsandservicessoldoperatingexpense": 8869000,
    "typeofcostgoodorserviceextensiblelist": "us-gaap:ProductMember",
    "researchanddevelopmentexpense": 252924000,
    "sellinggeneralandadministrativeexpense": 106406000,
    "operatingexpenses": 368199000,
    "operatingincomeloss": -191880000,
    "interestexpense": 2402000,
    "unconsolidatedvariableinterestentityinvestmentloss": 202000,
    "interestandotherincome": 5553000,
    "interestincomeexpensenonoperatingnet": 2949000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -188931000,
    "incometaxexpensebenefit": 360000,
    "netincomeloss": -189291000,
    "earningspersharebasicanddiluted": -2.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 89854000,
    "licensefeesandmilestonesrevenue": 14323000,
    "collaborationservicesandotherrevenue": 19174000,
    "productrevenue": 4281000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -3207000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -545000,
    "othercomprehensiveincomelossnetoftax": -3752000,
    "comprehensiveincomenetoftax": -193043000,
    "sharesoutstanding": 91440633,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -545000,
    "adjustmentstoadditionalpaidincapitalsharesissuedfromstockplansnetofpayrolltaxespaid": 37000,
    "sharesissuedfromstockplansnetofpayrolltaxespaidshares": 3783144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 72720000,
    "profitloss": -189291000,
    "depreciation": 11678000,
    "financeleaserightofuseassetamortization": 10369000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -103000,
    "investmentlossinunconsolidatedvariableinterestentity": -202000,
    "gainlossondispositionofassets": -933000,
    "sharebasedcompensation": 72720000,
    "availableforsalesecuritiesgrossrealizedgainlossexcludingotherthantemporaryimpairments": -258000,
    "increasedecreaseinaccountsreceivable": 11973000,
    "increasedecreaseininventories": 9175000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -123492000,
    "increasedecreaseinotheroperatingassets": -6843000,
    "increasedecreaseinaccountspayable": 17731000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 31048000,
    "increasedecreaseincontractwithcustomerliability": 45077000,
    "increasedecreaseinaccruedinterestforfinanceleaseliabilities": -177000,
    "increasedecreaseinothernoncurrentliabilities": -28236000,
    "netcashprovidedbyusedinoperatingactivities": 81602000,
    "paymentstoacquirepropertyplantandequipment": 3994000,
    "paymentmadeforinvestmentinunconsolidatedvariableinterestentity": 3896000,
    "proceedsfromequitytransferofunconsolidatedvariableinterestentity": 1063000,
    "paymentstoacquireavailableforsalesecuritiesandtermdeposit": 8192000,
    "proceedsfromsaleofavailableforsalesecurities": 10606000,
    "proceedsfromsalematurityandcollectionsofinvestments": 456900000,
    "netcashprovidedbyusedininvestingactivities": 452487000,
    "repaymentsoffinanceleaseliabilities": 12620000,
    "repaymentsofdebtandcapitalleaseobligations": 403000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 11463000,
    "proceedsfromissuanceofcommonstock": 37829000,
    "netcashprovidedbyusedinfinancingactivities": 13343000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 4695000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 552127000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 678393000,
    "interestpaidnet": 135000,
    "capitalexpendituresincurredbutnotyetpaid": 884000,
    "increasedecreaseinaccountsreceivablerelatedparties": 718000,
    "increasedecreaseinprepaidexpensesandothercurrentassetsrelatedparties": 124321000,
    "increasedecreaseinaccountspayablefromrelatedparty": 1118000,
    "increasedecreaseinaccountspayablerelatedparties": -36859000,
    "increasedecreaseindeferredrevenue": 7169000,
    "numberofoperatingsegments": 1,
    "concentrationriskpercentage1": 0.1,
    "highlyliquidinvestmentmaturityperiod": "three months or less",
    "shortterminvestmentsmaximummaturityperiod": "P12M",
    "longterminvestmentsminimummaturityperiod": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinestimateoftransactionprice": 6000000,
    "revenueperformanceobligationdescriptionofpaymentterms": "The period between the transfer of control of the promised goods and when the Company receives payment is based on a general 60-day payment term.",
    "descriptionofsalesreturn": "Distributors can request to return product to the Company only due to quality issues or for product purchased within one year prior to the productâ€™s expiration date",
    "businessacquisitionpercentageofvotinginterestsacquired": 0.489,
    "paymentstoacquirebusinessesgross": 8900000,
    "variableinterestentityownershippercentage": 0.511,
    "capital": 17500000,
    "equitymethodinvestmentadditions": 19200000,
    "equitymethodinvestmentownershippercentage": 0.511,
    "equitymethodinvestments": 2728000,
    "incomelossfromequitymethodinvestments": 202000,
    "equitymethodinvestmentincreasedecreasefromcurrencytranslation": 105000,
    "potentialmilestones": 22000000,
    "additionalconsiderationbasedonnetsales": "the low 20% range of the list price",
    "collaborativearrangementaggregateconsiderationexcludingdrugproductrevenue": 105100000,
    "transactionpriceallocatedtoperformanceobligations": 15000000,
    "revenueremainingperformanceobligation": 800000,
    "supplies": 2147000,
    "estimatedjointdevelopmentextendedserviceperiod": 2024,
    "collaborativearrangementaggregateconsideration": 77200000,
    "contractwithcustomerliabilitymilestonemethodrevenuerecognized": 12000000,
    "copromotionexpenses": 27200000,
    "accruedlongtermcopromotionliabilitynoncurrent": 27400000,
    "accruedlongtermcopromotionliabilitycurrent": 16900000,
    "proceedsfromnoncontingentupfrontpayments": 40100000,
    "variableconsiderationpaymentreceiveduponachievementofmilestone": 65000000,
    "variableconsiderationpaymentreceivedrelatedtocodevelopmentbillings": 11700000,
    "alternativeinvestmentmeasurementinput": 17.5,
    "codevelopmentservicesestimatedcontinuationyear": 2024,
    "variableconsiderationrelatedtoprofitshare": 7000000,
    "royaltyrateonnetrevenue": 0.4,
    "cumulativerevenuelicenseanddevelopmentrevenuerecognized": 100347000,
    "contractwithcustomerliability": 130000,
    "cashconsiderationreceivedundercollaborationagreement": 100347000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 15100000,
    "variableconsiderationpaymentreceivedfromestimatedfuturecodevelopmentbilling": 27600000,
    "suppliesnet": 2100000,
    "revenuegrossfromcontractwithcustomerexcludingassessedtax": 89027000,
    "allowancefordoubtfulaccountsreceivable": 800000,
    "contractwithcustomerliabilityadditions": 16497000,
    "contractwithcustomerliabilitydeduction": 2184000,
    "contractwithcustomerliabilityincreasedecreasefromcurrenttranslationandother": -270000,
    "contractwithcustomerliabilitygross": -15685000,
    "contractwithcustomerliabilitynetofaccountsreceivable": 548000,
    "availableforsalesecurities": 8144000,
    "cashandcashequivalentsfairvaluedisclosure": 590347000,
    "assetsfairvaluedisclosure": 590591000,
    "liabilitiesfairvaluedisclosure": 1141000,
    "numberoffinanceleases": 2,
    "lesseefinanceleaseoptiontoextend": "The Company has an option to extend the lease for an additional 10 years through 2033.",
    "numberofoperatingleases": 6,
    "lesseeoperatingleasetermofcontract": "P2Y",
    "lesseeoperatingleaseexpirationperiod": 2023,
    "financeleaserightofuseassetscost": 50477000,
    "financeleaseaccumulatedamortization": 20871000,
    "operatingleaserightofuseassetscost": 3934000,
    "operatingleaseaccumulatedamortization": 1891000,
    "operatingleaserightofuseasset": 2043000,
    "financeleaseandoperatingleaseassets": 31649000,
    "operatingleaseliabilitycurrent": 1188000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "fgen:AccruedAndOtherCurrentLiabilitiesMember",
    "operatingleaseliabilitynoncurrent": 853000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherNoncurrentLiabilitiesMember",
    "financeleaseandoperatingleaseliability": 39762000,
    "financeleaseinterestexpense": 1932000,
    "operatingleasecost": 1151000,
    "subleaseincome": 1201000,
    "leasecost": 12251000,
    "operatingleasepayments": 951000,
    "financeleaseinterestpaymentonliability": 1896000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 662000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1072000,
    "financeleaseweightedaverageremainingleaseterm1": "P2Y10M24D",
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y9M18D",
    "financeleaseweightedaveragediscountratepercent": 0.0439,
    "operatingleaseweightedaveragediscountratepercent": 0.0474,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 13689000,
    "financeleaseliabilitypaymentsdueyeartwo": 13886000,
    "financeleaseliabilitypaymentsdueyearthree": 12526000,
    "financeleaseliabilitypaymentsdue": 40101000,
    "financeleaseliabilityundiscountedexcessamount": 2380000,
    "financeleaseliability": 37721000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1142000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 839000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 143000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2124000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 83000,
    "operatingleaseliability": 2041000,
    "cash": 88046000,
    "moneymarketfundsatcarryingvalue": 590347000,
    "availableforsalesecuritiesamortizedcost": 8147000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 119000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecuritiesbondandmutualfundsmaturingwithinoneyear": 8144000,
    "availableforsalesecuritiesequitysecurities": 244000,
    "percentageofprelaunchinventorycapitalizedofaggregateinventorybalance": 0.29,
    "accruedlongtermcopromotionalliabilitynoncurrent": 27400000,
    "inventoryrawmaterials": 2303000,
    "inventoryworkinprocess": 8114000,
    "inventoryfinishedgoods": 6113000,
    "prepaidexpensecurrent": 8353000,
    "otherassetscurrent": 1807000,
    "propertyplantandequipmentgross": 102006000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 111247000,
    "accruedpreclinicalandclinicaltrialcurrent": 44113000,
    "employeerelatedliabilitiescurrent": 22800000,
    "accruedcontractliabilitiestopharmaceuticaldistributorscurrent": 15137000,
    "accruedcopromotionexpensescurrent": 11537000,
    "accruedprofitsharecurrent": 7007000,
    "propertytaxesandothercurrent": 5970000,
    "accruedprofessionalfeescurrent": 4869000,
    "otheraccruedliabilitiescurrent": 8088000,
    "accruedliabilitiescurrent": 119521000,
    "deferredtaxandotherliabilitiesnoncurrent": 8675000,
    "othersundryliabilitiesnoncurrent": 2690000,
    "numberofproductdevelopmentobligations": 11,
    "loansreceivablebasisspreadonvariablerate": 0.01,
    "debtinstrumentinterestratestatedpercentage": 0.03,
    "accruedproductdevelopmentcostsexcludinginterest": 11600000,
    "interestpayablecurrentandnoncurrent": 7100000,
    "contractualobligation": 86000000,
    "maximumfuturemilestonepayments": 10900000,
    "recordedunconditionalpurchaseobligationduewithinoneyear": 14114000,
    "recordedunconditionalpurchaseobligationdueinsecondyear": 10951000,
    "recordedunconditionalpurchaseobligation": 25065000,
    "preferredstockredemptionterms": "Redemption Right â€” If a Preferred Share can be redeemed by a majority shareholder owning more than ninety percent (90%)Â of the shares of FibroGen Europe in accordance with the provisions of the Finnish Limited Liability Companies Act, the minority holders of Preferred Shares have the right to request redemption of their shares.",
    "requiredminimumshareholderpercentagetocallforredemptionofpreferredshares": 0.9,
    "preferredstockvotingrights": "one vote",
    "convertiblepreferredstocksharesissueduponconversion": 1,
    "preferredsharesissuedpricepershare": 1,
    "preferredstockdividendratepercentage": 0.06,
    "commonstockvotingrights": "one vote",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9290000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1893000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 7910000,
    "commonstockcapitalsharesreservedforfutureissuance": 4070000,
    "commonstocksharesreserved": 114604000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-11-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Option vesting schedules are determined by the Company at the time of issuance and generally have a four year vesting schedule (25% vesting on the first anniversary of the vesting base date and quarterly thereafter over the next 3 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperioddescription": "Shares reserved for issuance increases on JanuaryÂ 1 of each year commencing on JanuaryÂ 1, 2016 and ending on JanuaryÂ 1, 2024 by the lesser of (i)Â the amount equal to 4% of the number of shares issued and outstanding on DecemberÂ 31 immediately prior to the date of increase or (ii)Â such lower number of shares as may be determined by the board of directors. As of DecemberÂ 31, 2020, the Company has reserved 7,909,854 shares of its common stock that remains unissued for issuance under the 2014 Plan.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 66943000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 526055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 29.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2692000,
    "stockissuedduringperiodsharesstockoptionsexercisedfullyear": 3113000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 73000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 234000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8929000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5576000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 32.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 31.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 39.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 40.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 32.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 29.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 86013000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 84125000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1354000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 813000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 131000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 37.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 45.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 39.25,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 143876,
    "allocatedsharebasedcompensationexpense": 46229000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.671,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.771,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.029,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.36,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 63900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M2D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 55500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6694000,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.6,
    "definedcontributionplancostrecognized": 3200000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -195617000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 6686000,
    "currentforeigntaxexpensebenefit": 360000,
    "currentincometaxexpensebenefit": 360000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationdeductionexpensesharebasedcompensationcost": 0.024,
    "effectiveincometaxratereconciliationbenefitonintercompanytransferofassets": 0.417,
    "effectiveincometaxratereconciliationvaluationallowanceonintercompanytransferofassets": -0.417,
    "effectiveincometaxratereconciliationnetoperatinglossesnotbenefitted": -0.232,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.007,
    "effectiveincometaxratereconciliationdeductions": -0.008,
    "effectiveincometaxratereconciliationotheradjustments": -0.003,
    "effectiveincometaxratecontinuingoperations": -0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 134033000,
    "deferredtaxassetstaxcreditcarryforwards": 62465000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 32417000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 10399000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 8243000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 5875000,
    "deferredtaxassetsdeferredincome": 13550000,
    "deferredtaxassetsintangibleassets": 75915000,
    "deferredtaxassetsgross": 342897000,
    "deferredtaxassetsvaluationallowance": 337824000,
    "deferredtaxassetsnet": 5073000,
    "deferredtaxliabilitiesfixedassets": 5073000,
    "deferredtaxliabilities": 5073000,
    "valuationallowancedeferredtaxassetchangeinamount": 124000000,
    "deferredtaxassetintraentitytransferassetotherthaninventory": 78700000,
    "operatinglosscarryforwardsexpirationyear": 2026,
    "deferredtaxassetstaxcreditcarryforwardsother": 66900000,
    "othertaxcreditcarryforwardsexpirationyear": 2021,
    "unrecognizedtaxbenefits": 48600000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 500000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleestimatedrangenotpossible": "The Company does not anticipate a material change to its unrecognized tax benefits over the next twelve months that would affect the Companyâ€™s effective tax rate.",
    "opentaxyear": 2011,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 137000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 16448000,
    "revenuefromrelatedparties": 33500000,
    "drugproductrevenuefromrelatedparty": 4300000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 500000,
    "miscellaneousreceivables": 900000,
    "revenues": 67161000,
    "valuationallowancesandreservesbalance": 337824000,
    "valuationallowancesandreserveschargedtocostandexpense": 123977000,
    "valuationallowancesandreserveschargedtootheraccounts": -14867000,
    "valuationallowancesandreservesdeductions": 2184000
  },
  {
    "date": "2019-12-30",
    "symbol": "FGEN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "FGEN",
    "entityregistrantname": "FIBROGEN, INC.",
    "entitycentralindexkey": 921299,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-36740",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "77-0357827",
    "entityaddressaddressline1": "409 Illinois Street",
    "entityaddresscityortown": "San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94158,
    "cityareacode": 415,
    "localphonenumber": "978-1200",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 126266000,
    "shortterminvestments": 407491000,
    "accountsreceivablenetcurrent": 28455000,
    "inventorynet": 6887000,
    "prepaidexpenseandotherassetscurrent": 133391000,
    "assetscurrent": 702490000,
    "restrictedtimedepositsnoncurrent": 2072000,
    "longterminvestments": 61118000,
    "propertyplantandequipmentnet": 42743000,
    "financeleaserightofuseasset": 39602000,
    "otherassetsnoncurrent": 9372000,
    "assets": 857397000,
    "accountspayablecurrent": 6088000,
    "accruedliabilitiesandotherliabilities": 83816000,
    "contractwithcustomerliabilitycurrent": 490000,
    "financeleaseliabilitycurrent": 12351000,
    "liabilitiescurrent": 102745000,
    "leaseobligationsnoncurrent": 1141000,
    "accruedproductdevelopmentcosts": 16780000,
    "deferredrentcreditnoncurrent": -3038000,
    "contractwithcustomerliabilitynoncurrent": 99449000,
    "financeleaseliabilitynoncurrent": 37610000,
    "otherliabilitiesnoncurrent": 64266000,
    "liabilities": 321991000,
    "commonstockvalue": 877000,
    "additionalpaidincapital": 1300725000,
    "accumulatedothercomprehensiveincomelossnetoftax": -747000,
    "retainedearningsaccumulateddeficit": -784720000,
    "stockholdersequity": 516135000,
    "minorityinterest": 19271000,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 535406000,
    "liabilitiesandstockholdersequity": 857397000,
    "accountsreceivablerelatedpartiescurrent": 4845000,
    "duefromrelatedpartiescurrent": 125210000,
    "duetorelatedpartiescurrent": 36883000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 125000000,
    "preferredstocksharesoutstanding": 42619022,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 225000000,
    "commonstocksharesissued": 87657000,
    "commonstocksharesoutstanding": 87657000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 177086000,
    "costofgoodsandservicessoldoperatingexpense": 1147000,
    "typeofcostgoodorserviceextensiblelist": "us-gaap:ProductMember",
    "researchanddevelopmentexpense": 209265000,
    "sellinggeneralandadministrativeexpense": 135479000,
    "operatingexpenses": 345891000,
    "operatingincomeloss": -89314000,
    "interestexpense": 2876000,
    "interestandotherincome": 15548000,
    "interestincomeexpensenonoperatingnet": 12672000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -76642000,
    "incometaxexpensebenefit": 328000,
    "netincomeloss": -76970000,
    "earningspersharebasicanddiluted": -0.89,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 86633000,
    "licensefeesandmilestonesrevenue": 129405000,
    "collaborationservicesandotherrevenue": 29393000,
    "productrevenue": -36324000,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 331000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 592000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 592000,
    "othercomprehensiveincomelossnetoftax": 923000,
    "comprehensiveincomenetoftax": -76047000,
    "sharesoutstanding": 87657489,
    "newaccountingpronouncementorchangeinaccountingprincipleeffectofchangeonnetincome": 8688000,
    "adjustmentstoadditionalpaidincapitalsharesissuedfromstockplansnetofpayrolltaxespaid": 23000,
    "sharesissuedfromstockplansnetofpayrolltaxespaidshares": 2220957,
    "warrantsexercisedduringperiodvalue": 66000,
    "warrantexercisedduringperiodshares": 4430,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 66267000,
    "profitloss": -76970000,
    "depreciation": 11147000,
    "financeleaserightofuseassetamortization": 10307000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 3667000,
    "unrealizedgainlossoncashequivalentsandshorttermequityinvestments": 88000,
    "gainlossondispositionofassets": 42000,
    "sharebasedcompensation": 66267000,
    "increasedecreaseinaccountsreceivable": -35229000,
    "increasedecreaseininventories": 6887000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 128598000,
    "increasedecreaseinotheroperatingassets": 3253000,
    "increasedecreaseinaccountspayable": -3051000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 18288000,
    "increasedecreaseincontractwithcustomerliability": -49941000,
    "increasedecreaseinaccruedinterestforfinanceleaseliabilities": 194000,
    "increasedecreaseinothernoncurrentliabilities": 52360000,
    "netcashprovidedbyusedinoperatingactivities": -78705000,
    "paymentstoacquirepropertyplantandequipment": 5762000,
    "proceedsfromsaleofpropertyplantandequipment": 7000,
    "paymentstoacquireavailableforsalesecuritiesandtermdeposit": 411299000,
    "proceedsfromsalematurityandcollectionsofinvestments": 537072000,
    "netcashprovidedbyusedininvestingactivities": 120018000,
    "repaymentsoffinanceleaseliabilities": 11925000,
    "repaymentsofdebtandcapitalleaseobligations": 403000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 12750000,
    "proceedsfromissuanceofcommonstock": 20778000,
    "netcashprovidedbyusedinfinancingactivities": -4300000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -5000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 37008000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 126266000,
    "interestpaidnet": 174000,
    "capitalexpendituresincurredbutnotyetpaid": 460000,
    "increasedecreaseinaccountsreceivablerelatedparties": 42365000,
    "increasedecreaseinprepaidexpensesandothercurrentassetsrelatedparties": -125210000,
    "increasedecreaseinaccountspayablerelatedparties": 36439000,
    "numberofoperatingsegments": 1,
    "highlyliquidinvestmentmaturityperiod": "three months or less",
    "shortterminvestmentsmaximummaturityperiod": "P12M",
    "longterminvestmentsminimummaturityperiod": "P12M",
    "propertyplantandequipmentusefullife": "P3Y",
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinestimateoftransactionprice": 36300000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "concentrationriskpercentage1": 0.17,
    "otherassets": 730000,
    "accruedandotherliabilitiescurrent": -619000,
    "longtermportionofcapitalleaseobligations": -95613000,
    "liabilitiesotherthanlongtermdebtnoncurrent": 250000,
    "potentialmilestones": 22000000,
    "additionalconsiderationbasedonnetsales": "low 20% range",
    "collaborativearrangementaggregateconsideration": 90100000,
    "transactionpriceallocatedtoperformanceobligations": 130000000,
    "contractwithcustomerliabilityrevenuerecognized": 18700000,
    "revenueremainingperformanceobligation": 128800000,
    "supplies": 130000000,
    "estimatedjointdevelopmentextendedserviceperiod": 2023,
    "contractwithcustomerliabilitymilestonemethodrevenuerecognized": 12000000,
    "proceedsfromnoncontingentupfrontpayments": 40100000,
    "variableconsiderationpaymentreceiveduponachievementofmilestone": 50000000,
    "variableconsiderationpaymentreceivedrelatedtocodevelopmentbillings": 11400000,
    "alternativeinvestmentmeasurementinput": 17.5,
    "codevelopmentservicesestimatedcontinuationyear": 2023,
    "royaltyrateonnetrevenue": 0.4,
    "cumulativerevenuelicenseanddevelopmentrevenuerecognized": 86024000,
    "contractwithcustomerliability": 375000,
    "cashconsiderationreceivedundercollaborationagreement": 86024000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 12100000,
    "variableconsiderationpaymentreceivedfromestimatedfuturecodevelopmentbilling": 45400000,
    "suppliesnet": 125200000,
    "revenuegrossfromcontractwithcustomerexcludingassessedtax": 2803000,
    "priceadjustmentchanges": -936000,
    "salesrebatesandotherdiscounts": -167000,
    "changeinestimatedvariableconsideration": 36300000,
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuechangeinmeasureofprogress": 900000,
    "availableforsalesecurities": 347383000,
    "cashandcashequivalentsfairvaluedisclosure": 85551000,
    "assetsfairvaluedisclosure": 444005000,
    "fairvalueassetslevel1tolevel2transfersamount": 29800000,
    "liabilitiesfairvaluedisclosure": 1544000,
    "numberoffinanceleases": 2,
    "lesseefinanceleaseoptiontoextend": "The Company has an option to extend the lease for an additional 10 years through 2033.",
    "numberofoperatingleases": 7,
    "lesseeoperatingleasetermofcontract": "P2Y",
    "financeleaserightofuseassetscost": 49909000,
    "financeleaseaccumulatedamortization": 10307000,
    "operatingleaserightofuseassetscost": 2736000,
    "operatingleaseaccumulatedamortization": 805000,
    "operatingleaserightofuseasset": 1931000,
    "financeleaseandoperatingleaseassets": 41533000,
    "operatingleaseliabilitycurrent": 983000,
    "operatingleaseliabilitynoncurrent": 942000,
    "financeleaseandoperatingleaseliability": 51886000,
    "financeleaseinterestexpense": 2373000,
    "operatingleasecost": 891000,
    "subleaseincome": 1385000,
    "leasecost": 12186000,
    "operatingleasepayments": 914000,
    "financeleaseinterestpaymentonliability": 2196000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 49909000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2736000,
    "financeleaseweightedaverageremainingleaseterm1": "P3Y7M6D",
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y1M6D",
    "financeleaseweightedaveragediscountratepercent": 0.0442,
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 14078000,
    "financeleaseliabilitypaymentsdueyeartwo": 13676000,
    "financeleaseliabilitypaymentsdueyearthree": 13878000,
    "financeleaseliabilitypaymentsdueyearfour": 12523000,
    "financeleaseliabilitypaymentsdue": 54155000,
    "financeleaseliabilityundiscountedexcessamount": 4194000,
    "financeleaseliability": 49961000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1043000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 668000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 307000,
    "lesseeoperatingleaseliabilitypaymentsdue": 2018000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 93000,
    "operatingleaseliability": 1925000,
    "cash": 40715000,
    "moneymarketfundsatcarryingvalue": 85551000,
    "availableforsalesecuritiesamortizedcost": 426995000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 536000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 25000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 407491000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfouryearsfairvalue": 50047000,
    "availableforsalesecuritiesdebtsecurities": 457538000,
    "availableforsalesecuritiesbondandmutualfunds": 10816000,
    "availableforsalesecuritiesequitysecurities": 255000,
    "inventoryrawmaterials": 325000,
    "inventoryworkinprocess": 2264000,
    "inventoryfinishedgoods": 4298000,
    "prepaidexpensecurrent": 6464000,
    "otherassetscurrent": 1717000,
    "numberofregulatorymilestones": 2,
    "propertyplantandequipmentgross": 101548000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 100364000,
    "accruedactivepharmaceuticalingredientproductpriceadjustmentcurrent": 36324000,
    "accruedlongtermcopromotionalliabilitynoncurrent": 53071000,
    "accruedpreclinicalandclinicaltrialcurrent": 16279000,
    "employeerelatedliabilitiescurrent": 19784000,
    "propertytaxesandothercurrent": 2044000,
    "accruedprofessionalfeescurrent": 4842000,
    "otheraccruedliabilitiescurrent": 4543000,
    "accruedliabilitiescurrent": 83816000,
    "deferredtaxandotherliabilitiesnoncurrent": 8913000,
    "othersundryliabilitiesnoncurrent": 1340000,
    "numberofproductdevelopmentobligations": 11,
    "loansreceivablebasisspreadonvariablerate": 0.01,
    "debtinstrumentinterestratestatedpercentage": 0.03,
    "accruedproductdevelopmentcostsexcludinginterest": 10600000,
    "interestpayablecurrentandnoncurrent": 6200000,
    "priorperiodreclassificationadjustment": 2100000,
    "descriptionoflesseeleasingarrangementsoperatingleases": "The agreement also included an expansion option to occupy part of an adjacent building, for which the Company gave notice to its landlord that it would not exercise this expansion option",
    "leaseincentivereceivable": 5000000,
    "maximumfuturemilestonepayments": 11000000,
    "preferredstockredemptionterms": "Redemption Right â€” If a Preferred Share can be redeemed by a majority shareholder owning more than ninety percent (90%)Â of the shares of FibroGen Europe in accordance with the provisions of the Finnish Limited Liability Companies Act, the minority holders of Preferred Shares have the right to request redemption of their shares.",
    "requiredminimumshareholderpercentagetocallforredemptionofpreferredshares": 0.9,
    "preferredstockvotingrights": "one vote",
    "convertiblepreferredstocksharesissueduponconversion": 1,
    "preferredsharesissuedpricepershare": 1,
    "preferredstockdividendratepercentage": 0.06,
    "commonstockvotingrights": "one vote",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 10018000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1483000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 7725000,
    "commonstockcapitalsharesreservedforfutureissuance": 3337000,
    "commonstocksharesreserved": 110220000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-11-12",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Option vesting schedules are determined by the Company at the time of issuance and generally have a four year vesting schedule (25% vesting on the first anniversary of the vesting base date and quarterly thereafter over the next 3 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsotherincreasesdecreasesinperioddescription": "Shares reserved for issuance increases on JanuaryÂ 1 of each year commencing on JanuaryÂ 1, 2016 and ending on JanuaryÂ 1, 2024 by the lesser of (i)Â the amount equal to 4% of the number of shares issued and outstanding on DecemberÂ 31 immediately prior to the date of increase or (ii)Â such lower number of shares as may be determined by the board of directors. As of DecemberÂ 31, 2019, the Company has reserved 7,724,691 shares of its common stock that remains unissued for issuance under the 2014 Plan.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 183707000,
    "restrictedstocksharesissuednetofsharesfortaxwithholdings": 448647,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 54.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1909000,
    "stockissuedduringperiodsharesstockoptionsexercisedfullyear": 1642000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 21000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 658000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 10018000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 7318000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 26.63,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 53.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 50.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 44.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 26.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y2M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y2M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P3Y10M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 193226000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 193226000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1110000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 715000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 340000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 49.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 37.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 46.15,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 135115,
    "allocatedsharebasedcompensationexpense": 41015000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.481,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.621,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.029,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 31.98,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 57500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M25D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 52900000,
    "classofwarrantorrightnumberofwarrantsorrightsexercisedduringperiod": 4430,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7602000,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 0.6,
    "definedcontributionplancostrecognized": 3000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 2538000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -79180000,
    "currentforeigntaxexpensebenefit": 328000,
    "currentincometaxexpensebenefit": 328000,
    "effectiveincometaxratereconciliationdeductionexpensesharebasedcompensationcost": 0.063,
    "effectiveincometaxratereconciliationnetoperatinglossesnotbenefitted": -0.029,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.217,
    "effectiveincometaxratereconciliationdeductions": -0.025,
    "effectiveincometaxratereconciliationotheradjustments": -0.006,
    "effectiveincometaxratecontinuingoperations": -0.004,
    "deferredtaxassetsoperatinglosscarryforwards": 91267000,
    "deferredtaxassetstaxcreditcarryforwards": 52243000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 37786000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 11159000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 10698000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 5353000,
    "deferredtaxassetsdeferredincome": 13323000,
    "deferredtaxassetsother": 284000,
    "deferredtaxassetsgross": 222113000,
    "deferredtaxassetsvaluationallowance": 213847000,
    "deferredtaxassetsnet": 8266000,
    "deferredtaxliabilitiesfixedassets": 8266000,
    "deferredtaxliabilities": 8266000,
    "valuationallowancedeferredtaxassetchangeinamount": 19900000,
    "operatinglosscarryforwardsexpirationyear": 2026,
    "deferredtaxassetstaxcreditcarryforwardsother": 54100000,
    "othertaxcreditcarryforwardsexpirationyear": 2020,
    "unrecognizedtaxbenefits": 32300000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 500000,
    "significantchangeinunrecognizedtaxbenefitsisreasonablypossibleestimatedrangenotpossible": "The Company does not anticipate a material change to its unrecognized tax benefits over the next twelve months that would affect the Companyâ€™s effective tax rate.",
    "opentaxyear": 2010,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 4418000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 111000,
    "revenuefromrelatedparties": 122500000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 2800000,
    "revenues": 132400000,
    "valuationallowancesandreservesbalance": 213847000,
    "valuationallowancesandreserveschargedtocostandexpense": 19860000
  }
]